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ABSTRACT 
Background 
Methamphetamine abuse “TIK” is highly prevalent in South Africa with Cape Town recording the highest 
incidence. This is associated with significant health, social and economic problems in South Africa. The aim of the 
continually growing number of rehabilitation centres in South Africa has been to provide treatment and support 
for substance abusers towards abstention from substance abuse. This study looked at the performance outcome 
of the rehabilitation programme at the largest state funded treatment centre, De Novo, in Cape Town.   
Aim 
This study examines the performance of the rehabilitation programme for amphetamine abuse at De Novo 
treatment centre in Cape Town over a period of one year. 
Methods 
Design and setting: A quantitative, descriptive cross-sectional survey was done. The setting was De Novo 
treatment centre situated in Kraaifontein, Cape Town. Data was collected from 91 client folder records out of a 
total population of 375 who received 7 weeks in-patient treatment and varying periods of aftercare over a period 
of one year  
Measuring tools: Patient self-reporting was used in this study to assess abstinence from amphetamine use. 
Results 
The time period of aftercare after discharge from in-patient treatment was inadequate i.e. less than 6 months.  
Final aftercare assessments were done too early i.e. at a mean of 3.8 months after discharge for an accurate 
assessment of treatment outcome to be made. This early aftercare assessment gave De Novo treatment centre a 
good initial performance outcome.  A total of 73.6% of clients self- reported abstinence but they were assessed 
only at a median time of 2 months after discharge. These clients who abstained were interviewed early at a 
median of 2 months while those who relapsed were interviewed at a median of 5 months. The amphetamine 
rehabilitation performance outcome cannot be accurately determined beyond 2 months for abstainers and 5 
months for those who relapsed. However Mann Whitney U analyses showed that the rate of relapse increased 
with time after discharge from in-patient treatment. Treatment admissions showed a predominance of male 
(69.2%) unemployed clients(79.1%). The outcome of rehabilitation was not affected by patient age, gender, 
employment status, educational level, type of referral and co-using any other substances except alcohol. Alcohol 
and prolonged amphetamine abuse are associated with increased relapse rates. Prolonged amphetamine use i.e. 
≥7.5 years was associated with increased relapse rates. 
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Conclusion: 
This study found that the provision of adequate rehabilitation from amphetamine abuse at De Novo is a major 
challenge due to the occurrence of early relapse and inadequate after care. Patients relapsed as early as two 
months after discharge from in-patient treatment. The co-abuse of alcohol and amphetamine as well as 
prolonged use of amphetamine for ≥7.5 years impacted negatively on the successful outcome of rehabilitation. 
This latter group of patients may require special attention during in-patient treatment and aftercare. The 
substance abuse programme at De Novo may benefit from the input of lessons learned from similar programmes 
elsewhere in South Africa and internationally. In particular, patients need to be followed up for at least 6 months 
after discharge from treatment. The median two month period of aftercare follow up of patients at De Novo was 
inadequate. 
There are no conflicts of interest. 
 
LITERATURE REVIEW 
The focus of this research is Methamphetamine abuse.  The researcher is particularly interested in this area of 
research because of clinical exposure to so many methamphetamine abusers and their consequent stressed 
parents. Rehabilitation of amphetamine abusers has appeared to be poorly successful. The reasons for the 
presumably poor success rate are speculative at this point in time since not enough well controlled studies have 
been conducted both internationally as well as locally. It is not widely known how rehabilitation centres in South 
Africa approach the problem and how successful they are with their rehabilitation programmes. The researcher 
initially planned to study the causes of presumed poorly successful rehabilitation but such a study needed prior 
baseline studies to confirm success or failure of rehabilitation programmes. There exists unfortunately insufficient 
information available from studies about the success rates of rehabilitation programs in South Africa and Cape 
Town. For this reason it was decided to settle for just doing a study to determine the actual success of 
rehabilitation centres in particular De Novo treatment centre. 
As amphetamine abuse increased in South Africa it brought about its related health, social and economic 
problems. Health facilities experienced an increase in amphetamine related mental health and physical illness. 
Community health as well as psychiatric hospitals has struggled to cope with the influx of patients with 
amphetamine related disorders [1,2]. With the shortage of hospital beds and the South African government policy 
shift towards integration and treatment of patients with mental health disorders into the community as well as 
the long wait for appointments at rehabilitation centres, it became necessary to focus on the development of 
effective rehabilitation facilities [3]. This research examines the effectiveness of one such rehabilitation facility. In 
Stellenbosch University  https://scholar.sun.ac.za
5 
 
5 
 
order to appreciate the difficulties faced by rehabilitation facilities it is worth stating the magnitude of the 
problem in terms of prevalence of amphetamine abuse, its health and social consequences. 
Prevalence of amphetamine use 
There has been a marked increase in the abuse of amphetamine worldwide and in South Africa in particular with 
the Western Cape reporting the biggest South African proportion of this increase [4,5,6,7].   
In the second half of 2011 the number of patients treated for drug abuse in various provinces in South Africa were 
as follows: Western Cape (2733), Eastern Cape (721), Gauteng (2786), KZN (610), Mpumalanga/Limpopo(892), 
Free State/Northern Cape/North West (549) [8].  
During the same period the patients treated for methamphetamine abuse as a proportion of total drug abuse 
treatment were as follows:  Western Cape (52.1%), Eastern Cape (22.7%), Gauteng (3.9%), KZN (0.9%), 
Mpumalanga/Limpopo (3.5%), Free State/Northern Cape/North West (3.8%) [8,9].  
  Until 2003 most drugs abused in South Africa consisted of cannabis and alcohol while methamphetamine was 
used on a small scale [1,10,11]. However post 2003 the abuse of methamphetamine in South Africa - more 
specifically Cape Town - showed such a dramatic rise that it eclipsed the abuse of other drugs like cannabis and 
alcohol amongst the youth [8,9,12,13].  
A 2012 SACENDU (South African Community Epidemiology Network on Drug Use) report revealed an increase in 
adult methamphetamine drug abuse in Cape Town during the period 2006 to 2011 [8].  
Usage and Associated illnesses 
Chronic methamphetamine use is associated with permanent cognitive impairment [14,15]. Following cessation 
of methamphetamine use, the withdrawal symptoms of depression, anxiety and fatigue can persist for up to 12 
months [16,17,18,19,20]. These justifies the importance of long term treatment and follow up of patients after 
discharge from inpatient or short term outpatient rehabilitation [21,22]. For this reason monitoring of patients 
after discharge from treatment has to be done over an extended period of time i.e. from 6 months up to 18 
months [19,20,21,23,24]. Cessation of monitoring prior to 6 months may not provide a true reflection of the 
success of the rehabilitation. 
The social scientific value of this research 
Rehabilitation of patients from substance abuse has been a major challenge and amphetamine abuse in particular 
has been a challenge because of the severe medical, social and economic adverse consequences it has had on 
South African society [13,25,26,27]. It appears ineffective since so many victims of methamphetamine abuse 
either choose not to go for rehabilitation or return to methamphetamine abuse not long after completing their 
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rehabilitation programmes [13,22]. The highly addictive properties of methamphetamine coupled with its rising 
scale of use resulted in increased demands put on already strained mental health services [16,17,28] .Drug 
counselling and treatment centres have struggled to cope with the volume of methamphetamine abusing patients 
and ensuring the institution of effective methamphetamine rehabilitation programmes [29]. Research on the 
effectiveness of these rehabilitation programmes is wanting on both international and national level. If 
methamphetamine abuse has such a vastly negative impact on South African society, one wonders how serious 
South African society sees this problem, how it attempts to deal with this problem and how successful these 
attempts have been. 
In order to deal with the problem, Rehabilitation centres- in addition to already existing health facilities- have 
been established all over South Africa. One such rehabilitation centre is De Novo, in Cape Town. It is not widely 
known how these centres approach the problem and how successful they are with their rehabilitation 
programmes.  It thus became necessary and beneficial to South African society to do a study of the problem and 
how successful they are at De Novo. De Nova is the largest rehabilitation centre in Cape Town and is 100% state 
funded. A study of De Novo may be used as a window through which other rehabilitation centres in South Africa 
can be looked at, hence the present research at De Novo.      
Previous studies on success of amphetamine rehabilitation 
There is no clinical evidence of efficacious pharmacotherapy in the treatment of patients with amphetamine 
abuse [6,22,30,31,32]. However, there is clinical evidence that psychotherapy is efficacious in the treatment of 
patients with amphetamine abuse [21,33,34,35,36]. Three psychosocial interventions have been shown to be of 
significant benefit i.e. brief motivational interviewing, cognitive behaviour therapy and contingency management 
[31,37,38]. Of the three, cognitive behaviour therapy has been considered as best practice [31,37,38]. The Matrix 
model is an outpatient treatment plan which uses amongst others, cognitive behaviour therapy [38,39]. 
Amphetamine treatment studies in South Africa are limited. However a number of amphetamine treatment 
studies have been done in Europe and America [37]. These studies are limited in quantity and quality [37]. 
Current evidence indicates that there is no single psychosocial intervention which is able to address the entire 
complex issues involved [22,34,40]. This same evidence also “reports little significant behavioural changes with 
reductions in rates of drug consumption following an intervention” [40]. It refers in particular to the 
successfulness of patients to remain rehabilitated for months to years following discharge from rehabilitation 
programmes. However, individual studies had shown some results [41].   
The studies found that both brief motivational interviewing and cognitive behaviour therapy have proven to 
significantly reduce the use of methamphetamine amongst patients.  
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In another randomised controlled study - the largest of its kind- by The Centre for Substance Abuse Treatment 
(CSAT) Methamphetamine Treatment Project (MTP) in the United States 2003 , the Matrix model was compared 
with TAU (treatment as usual) [23].  In this study the Matrix model showed better in- patient results than TAU. 
However, after discharge the Matrix Model did not show better success than TAU [23]. This is in keeping with the 
above Cochrane review [40]. A review done in 2008 found that cognitive behaviour therapy increases 
amphetamine abstinence rates after discharge from in-patient treatment while contingency management proved 
only effective during in-patient treatment [6]. Again this is in keeping with the above Cochrane review [40]. 
In South Africa experts in the field agree that treatment outcomes have been poor and a “dismal failure” [25]. An 
MRC Medical Research Council (MRC) scientist labeled prevention strategies in South Africa as “ineffective and 
misdirected” [25].  
Tools to measure abstinence from amphetamine use 
Abstinence from amphetamine use is highly important in methamphetamine rehabilitation [21,37,42]. 
Methamphetamine’s short half-life reduces the reliability of urine sample testing for amphetamine because the 
drug is eliminated from the body within less than a week. Thus, using such a test to monitor amphetamine use 
can only be useful if it is done at least once every week. Even then, the urine tests have been described as not 
highly sensitive and specific for amphetamine and in addition may even give false positive results [16]. “A true-
positive result in a sick client does not necessarily indicate that the presenting illness is due to methamphetamine 
toxicity [16]”. “The lack of correlation between serum or urine concentrations and clinical effects means such 
tests are of limited value in acute management of the patient and should not be considered a routine component 
of assessment procedures [16]”. 
Some studies used the urine amphetamine test to confirm abstinence [21,22,37]. The test would be done once 
per week during in-patient treatment and as spot tests at 6 and 12 month intervals. This is where the reliability of 
the urine test is brought into question because the test result only reveals amphetamine use within one week 
after stopping drug usage. Abstinence during in-patient treatment was defined as three consecutive 
methamphetamine- free urine tests [21,22,37]. However, the greatest difficulty in maintaining abstinence will be 
after discharge from in-patient treatment. A negative spot urine drug test done at 6 or 12 months will not provide 
information of amphetamine use during the periods day 1 after discharge and two weeks prior to the negative 
urine test. In an attempt to improve study instrument validity, many studies used a combination of the 
amphetamine urine test and psychometric methods to confirm abstinence from amphetamine use. Psychometric 
methods consists of standardised structured questionnaires in which a counselor and/or patient completes and 
includes patients self-reports of abstinence.   These questionnaires include questions from various angles which 
allow the patient to be given a score. These scores are quantified, valuated, categorized and labeled and used to 
get an overall assessment of patient outcome. A well done systematic review to identify psychometric assessment 
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tools identified 595 available tools of which only the following 6 tools qualified as having “merit” and as suitable 
for use in practice:  
Addiction severity index (ASI), Chemical Use, Abuse and Dependence Scale (CAUD), Form 90, Maudsley Addiction 
Profile (MAP), Measurements in the Addictions for Triage and Evaluation (MATE) and Substance Abuse Outcomes 
Module (SAOM) [24].This review concluded that ASI and CAUD are the two instruments best suited for routine 
clinical use [24] 
Reliability and Validity of Patient self-reported abstinence  
Patient self-reported abstinence has been widely used and accepted internationally as a screening tool for 
substance use [43,44]. Various studies of test validity have found good concordance – 80% to 88%- between 
patient self-reported abstinence and toxicology tests [21,22,37,44,45]. Patients who self-reported abstinence 
were also found to have negative urine test results [22]. In some studies patients self-reported higher drug use 
than what was found with the urinalyses tests [22,44]. Doing research to compare self-reported abstinence and 
urine drug tests tend to have the confounding variable that the one test exerts on the other when it is done on 
the same population. Yet, performing a valid comparison of these two tests can only be done when the same 
population is used. An important influencing factor on test reliability and validity is the conditions under which 
the interviews take place e.g. whether interviews are conducted in a private, unbiased, non-judgmental way and 
patient confidentiality is protected. A confounding variable might have been the influence of being referred by 
the criminal justice system on patient co-operation with treatment and truthfulness when interviewed after 
discharge.  However, studies using patient-self reporting found that patients referred by the criminal justice 
system had similar treatment outcomes to those who took voluntary treatment [21].  
 
AIM 
The aim of the research is to describe the success rate of the rehabilitation program for users and abusers of 
amphetamine at De Novo, Cape Town. 
 
 
OBJECTIVES 
The objectives of the study included: 
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1. To determine the number of patients who continue to self- report abstinence from amphetamine use up 
to 12 months after discharge from rehabilitation 
2. To determine any associations  between successful rehabilitation and gender, employment status, 
voluntary as well as court referrals 
3. To describe the profile of illicit drugs used by patients admitted to De Novo 
4. To record the current capacity and staff qualifications at De Novo to manage amphetamine abusers 
5. To describe the rehab methods used for amphetamine abusing patients at De Novo 
6. To describe the assessment methods used for amphetamine abusing patients at De Novo 
 
 
METHODS 
Design:  
A quantitative retrospective study by using patient records was done.  
Setting 
The study was done at De Novo Treatment centre, situated on Old Paarl Road in Kraaifontein. It is a very 
popular, well known treatment centre with a long history and good rapport with the communities around 
Cape Town. The centre is state-owned and under the management of Department of Social Development, 
Western Cape. It can accommodate about 100 adult in-patients at one time. The centre provides assistance 
for patients with substance abuse or use problems. These substances include alcohol, cannabis, cocaine, 
heroin and methamphetamine “Tik”. Currently only in-patient treatment is provided. All in-patients are 
expected to adhere to a 7 week structured programme of treatment. Voluntary indigent as well as patients 
referred by the criminal justice system are accepted for treatment. Approximately 540 patients are seen at 
the centre per year. It has about 92-95% occupancy at any time. During the period 2009 and 2010 a pilot post-
treatment follow up program has been implemented through which aftercare reports  were  kept of patient 
progress after discharge from treatment. As this pilot project was temporary and required additional funding 
the plan was for the aftercare pilot project to be terminated at some stage. The manager of the centre is Ms. 
C Fledermaus. De Novo’s reception can be contacted at Tel: 0219881108. The Postal address is Private Bag X1, 
Kraaifontein, 7569. 
Sampling 
The management of De Novo used its own client records to count the total number of patients admitted over the 
period 1 January 2009 till 31 December 2009.  
General method of investigation 
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A sample of folder records of patients admitted to De Novo during the period 1 January 2009 till 31 December 
2009 was assessed. Patients’ personal identifiable information e.g. name and address were not required. In 
circumstances where personally identifiable information accidentally appeared in copies of patient folders, such 
information was not captured in any data collection tools. The collected data was analysed with the assistance of 
the Centre for Statistical Consultation (University of Stellenbosch).  
 
Ethical approval was applied for and granted by both the University of Stellenbosch research ethics committee 
and the Western Cape Department of Social development research ethics committee. The application for ethical 
approval to the Department of Social development Western Cape research ethics committee included an 
additional PAIA [46] application form. The PAIA application proved to be a challenge. The Department of Social 
development Western Cape research ethics committee needed to consult its legal representatives prior to 
granting access to information recorded in patients’ folders while the researcher had to consult the South African 
Human Rights Commission (SAHRC) [46]. In order to understand PAIA applications, the researcher needed to 
study the entire PAIA act. The fact that the Department of Family Medicine (University of Stellenbosch) had no 
prior comparable ethics application made this the first ethics application of its kind.  This added to the waiting 
time to get PAIA approval.   
No pilot study was done because the PAIA application became an obstacle in the way of doing a timeous pilot 
study prior to doing the main research because a pilot study would have needed its own PAIA application.  
Inclusion Criteria 
1) All adult inpatients irrespective of gender who was admitted and treated for amphetamine abuse at  De 
Novo treatment centre over the period 1 January 2009 till 31 December 2009 
2) Court referrals 
 A rehab court referral refers to patients who reported to a social worker for misdemeanours e.g. 
family disruption but who coincidentally admitted to abusing substances. 
 Criminal court referrals are patients who were accused of committing crimes and coincidentally 
admitted to abusing substances. 
 
Exclusion Criteria 
1. All patients aged younger than eighteen years 
2. All patients who either did not use methamphetamines as a single drug or in combination with other illicit 
drugs 
3. Patients who did not complete the inpatient treatment program 
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Data collection 
The following information was extracted as variables from the case folders by using an Ms Excel spread sheet: 
Gender, employed, type of referral (rehab court vs. criminal court vs. voluntary), date of interview after discharge 
from in-patient treatment, patient self-report of abstention from substance use, relapse date, type of substances 
used, number of years of amphetamine use, type of treatment given, duration of treatment and type of follow up 
treatment.  
Data analyses 
The data was analysed by using STATISTICA version 9 [47].  
The primary objective of the study, as stated previously, was to estimate the overall success rate within the 
population of interest.  In order to estimate this success rate in the population the proportion of abstainers were 
calculated as well as 95% confidence intervals in order to express the uncertainty in the sample estimate of the 
population proportion. In order to examine possible differences or relationships between the success rate and the 
above-mentioned group’s chi-squared tests of association were performed.  The following general analysis rules 
were applied for all other analyses: Summary statistics were used to describe the variables.  Distributions of 
variables were presented with histograms and/or frequency tables. Medians or means were used as the measures 
of central location for ordinal and continuous responses and standard deviations and quartiles as indicators of 
spread. 
Relationships between two continuous variables were analysed with Chi-square  tests and the strength of the 
relationships were measured with the Pearson, M-L, Yates and McNemar correlation, if the continuous variables 
were not normally distributed. The relationships between continuous response variables and nominal input 
variables were analysed using appropriate analysis of variance (ANOVA). When ordinal response variables were 
compared versus a nominal input variable, a non-parametric ANOVA method was used. For this completely 
randomized design the Mann-Whitney U test was used.   
The relation between two nominal variables was investigated with contingency tables and likelihood ratio chi-
square tests. A p-value of p < 0.05 represented statistical significance in hypothesis testing and 95% confidence 
intervals were used to describe the estimation of unknown parameters. 
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RESULTS 
Table 1 shows the different members of staff, numbers and qualifications available at De Novo centre.  
Table 1 
 
Sampling 
Of the original sample of 557 patients only 375 was recorded as having met the sampling criteria. 
Each of the 375 patient folders was indexed by De Novo after which only the indexed list was forwarded to the 
researcher. This was in line with PAIA [46]. An adequate sample size was calculated to be 20.92% with at least a 
95% confidence interval. The researcher selected a sample of 91 cases i.e. 24% in case some folder records 
contained incomplete information. A random number generator tool [48] was used to create a simple non-
duplicating table of random numbers between 1 and 375. Staff at De Novo made copies only of relevant pages of 
the random list of 91 indexed folders. This was done to reduce the cost of making photocopies of entire folders. 
The copy process involved removing the personally identifiable information. 
 
 No. Qualifications Job description 
Social workers 7 registration with professional body case managers and performed group therapy 
sessions 
Occupational therapists 2 Registration with HPCSA managed creativity activities, life skills and 
stress management 
Occupational therapy 
assistant 
1 Registration with HPCSA Assisted with managing creativity activities, life 
skills and stress management 
Professional nurse 4 Grade 2 specialty in psychiatry. 
Registration with HPCSA 
Evaluation , counseling and clinical problems  
Enrolled nursing assistant 2 Registration with HPCSA Assisted the professional nurses  
Care staff 30 School grades 10 to 12. Experience 
and interest in community work 
assisted with 24 hour supervision of in-patients 
as well social skills sessions like library skills, 
gardening, etc. 
Aftercare interns 22 School grade 12, interest and 
experience with community work 
conducted aftercare reporting throughout the 
Western Cape for a period of 2 years. 
Religious groups varied  Offered variety of religious programmes 
Volunteer workers varied  assisted with life skill sessions 
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Characteristics of the sample population 
These were characterized as follows (see table 1): mean age in years was 24.6 (95% CI: 23.5- 25.8, SD 5.6), female 
(30.8%)  male (69.2%), employed (19.8%), unemployed (79.1%) missing employment status (1.1%), voluntary 
(44.0%) rehab court (7.7%) criminal court (48.3%). 
Table 1 
Characteristics of the sample population N=91 
Category Count N=91 % 
Female 28 30.8 
Male 63 69.2 
Unemployed 72 79.1 
Employed 18 19.8 
Missing employment status 1 1.1 
Voluntary 40 44.0 
Criminal Court 44 48.3 
Rehab court 7 7.7 
 
Co-abused substances occurred as follows (see table 2): cannabis (53.8%) mandrax (35.2%) alcohol (18.7%) 
cocaine (4.4%) heroin (3.3%) other (4.4%).  
 Table 2 
Co-abused substances  
Co-Abused 
Substance 
Usage 
Yes/No 
Count  % 
Cannabis 
No 41 45.1 
Yes 49 53.8 
Missing 1 1.1 
Alcohol 
No 61 67.0 
Yes 17 18.7 
Missing 13 14.3 
Mandrax 
No 58 63.7 
Yes 32 35.2 
Missing 1 1.1 
Heroin No 85 93.4 
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Yes 3 3.3 
Missing 3 3.3 
Cocaine 
No 85 93.4 
Yes 4 4.4 
Missing 2 2.2 
Other 
No 85 93.4 
Yes 4 4.4 
Missing 2 2.2 
 
Other variables included  :  cognitive behavior therapy (100%), group therapy (100%) and brief motivational 
interviewing (100%), referral to local social workers (100%), referral to local substance abuse support groups 
(100%), mean length of substance use was 5.7 years (95% CI: 4.6- 6.8,SD 4.0) . The minimum length of substance 
use was 1 year with a maximum of 25 years  
(see table 3). Clear records about the attendance of patients at social workers offices and support groups were 
not available. Many patients used three substances combined e.g. methamphetamine, alcohol and cannabis 
hence the substance co-abuse percentages adds to a total greater than 100%. Many patients (n=31) did not have 
very good educational backgrounds with some completing matric and one having reached technikon level at the 
time of in-patient treatment. The mean time of interview after discharge was 3.8 months (95% CI: 3.2- 4.4, SD 3.0) 
(see table 3).. A total of 31% of patients were interviewed within the 1 month and 45% of patients within the first 
2 months after discharge from treatment (see figure 1). 
 
 
Table 3 Characteristics of sample population 
 
Variable 
Valid N Mean 
Confidence - -
95% 
Confidence - 
95% 
Median Minimum Maximum Std.Dev. 
Age yrs 91 24.62637 23.45704 25.79570 23.00000 18.00000 46.00000 5.614759 
Time of Interview after 
discharge in months 
91 3.80568 3.18107 4.43029 3.00000 0.10000 12.00000 2.999173 
Length of drug use yrs 49 5.71429 4.57890 6.84968 5.00000 1.00000 25.00000 3.952847 
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Figure 1 
 
Characteristics of patients who self-reported abstention at time of aftercare interview 
These patients were interviewed at a mean of 3.4 months (95% CI: 2.7- 4.1, median 2, SD 2.9) after discharge. 
Abstention was self –reported by 67 patients (73.6%). These were characterized as follows  
(see table 4) : age 24.4 years (95% CI: 23.1- 25.7, SD 5.3) female (31.3%) male (68.7%), employed (20.9%) 
unemployed (77.6%) missing employment status (1.5%), voluntary (44.8%) rehab court (8.9%) criminal court 
(46.3%).  
Table 4 
Abstaining at time of Interview  N=67 
Category Count N=67 % 
Male 46 68.7 
Female 21 31.3 
Employed 52 20.9 
Unemployed 14 77.6 
Missing employment status 1 1.5 
Voluntary 30 44.8 
Rehab court 6 8.9 
Criminal Court 31 46.3 
 
Histogram of Time of Interview after discharge in months 
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Co-abused substance use occurred as follows (see table 5): cannabis (50.7%) alcohol (11.9%) mandrax (35.8%) 
heroin (4.5%) cocaine (4.5%) other (3%). 
 Table 5 
Abstaining at time of Interview  N=67 
Co-Abused 
Substance 
Usage 
Yes/No 
Count 
N=67 
% 
Cannabis 
No 32 47.8 
Yes 34 50.7 
Missing 1 1.5 
Alcohol 
No 49 73.13 
Yes 8 11.94 
Missing 10 14.93 
Mandrax 
No 42 62.7 
Yes 24 35.8 
Missing 1 1.5 
Heroin 
No 61 91.0 
Yes 3 4.5 
Missing 3 4.5 
Cocaine 
No 62 92.5 
Yes 3 4.5 
Missing 2 3.0 
Other 
No 63 94.0 
Yes 2 3.0 
Missing 2 3.0 
 
Nine patients who self-reported abstention at the time of the interview also reported that they had previously 
relapsed at 1.3 months (N=9, 95% CI: 0.5- 2.2, SD 1.0) (see table 6). The relapse times were as follows: 33% within 
2 weeks, 66% within 1 month, 77% (1.5-2 months) and 100% (2.5-3 months) after discharge from treatment. The 
mean length of substance use was 4.8 years (95% CI: 3.8- 5.9, SD 2.8) (see table 6). 
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Characteristics of patients admitting to amphetamine use at time of aftercare interview 
These patients were interviewed at a mean of 5.0 months (95% CI: 3.8- 6.2, median 5, SD 2.9) after discharge. 
Methamphetamine use was self-reported by 24 (26.4%) patients. These were characterized as follows (see table 
7): age 25.2 years (95% CI: 22.5- 27.9, SD 6.4) female (29.2%) male (70.8%), employed (16.7%) unemployed 
(83.3%), voluntary (41.6%) rehab court (4.2%) criminal court (54.2%).  
Table 7 
Using Amphetamine at time of Interview  N=24 
Category Count % 
Male 17 70.8 
Female 7 29.2 
Employed 4 16.7 
Unemployed 20 83.3 
Voluntary 10 41.7 
Rehab court 1 4.2 
Criminal Court 13 54.1 
 
Co-abused substances occurred as follows (see table 8): cannabis (62.5%) alcohol (37.5%) mandrax (33.3%) heroin 
(0%) cocaine (4.2%) other (8.3%).  
 
 
 
Table 6 Abstainers who relapsed previously N=9 
 
Variable 
Valid N Mean 
Confidence - -
95% 
Confidence - 
95% 
Median Minimum Maximum Std.Dev. 
Time of Interview after 
discharge in months 
91 3.80568 3.18107 4.43029 3.00000 0.10000 12.00000 2.999173 
If Abstaining at Time of 
Interview, time of previous 
relapse after discharge 
9 1.33704 0.50328 2.17079 1.00000 0.03333 3.00000 1.084672 
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 Table 8 
Abstaining at time of Interview  N=24 
Co-Abused 
Substance 
Usage 
Yes/No 
Count 
N=24 
% 
Cannabis 
No 9 37.5 
Yes 15 62.5 
Missing 0 0 
Alcohol 
No 12 50.0 
Yes 9 37.5 
Missing 3 12.5 
Mandrax 
No 16 66.7 
Yes 8 33.3 
Missing 0.0 0.0 
Heroin 
No 24 100 
Yes 0.0 0.0 
Missing 0.0 0.0 
Cocaine 
No 23 95.8 
Yes 1 4.2 
Missing 0.0 0.0 
Other 
No 22 91.7 
Yes 2 8.3 
Missing 0.0 0.0 
 
The mean time of relapse for non-abstainers was 0.9 months (N=16, 95% CI: 0.4- 1.5, SD 1.2) (see table 9). The 
relapse times were as follows: 62% within 2 weeks, 76% within 1 month, 86% (1.5-2 months), 95% (2.5-3 months) 
and 100% (3.5-4 months) after discharge from treatment. The mean length of substance use was 7.5 years (95% 
CI: 4.7- 10.3, SD 5.3). 
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Statistical analyses 
Pearson Chi-square tests to examine for associations between different variables and abstention produced the 
following results as shown in Table 10: 
Table 10: Associations between different variables and abstentions 
 Association present?  
yes(Y) no (N) 
P-value 
gender and abstention N 0.842 
employment and abstention N 0.63 
type of referral i.e. voluntary vs. criminal court vs. rehab 
court and abstention 
N 0.67 
alcohol and abstention Y Patients who abstained from alcohol also 
abstained from methamphetamine use 
0.006 
co-using cannabis and abstention N 0.35 
co-using mandrax and abstention N 0.79 
co-using heroin and abstention N 0.28 
co-using cocaine and abstention N 0.927 
co-using any other drugs and abstention N 0.288 
 
A Mann-Whitney U test and Box-Plot to compare non parametric data which did not follow normal distribution 
produced the following results: 
I. there was no association between age and abstention 
Table 9      Amphetamine users, Time of relapse     
 
Variable 
Valid N Mean 
Confidence - -
95% 
Confidence - 
95% 
Median Minimum Maximum Std.Dev. 
Age yrs 91 24.62637 23.45704 25.79570 23.00000 18.00000 46.00000 5.614759 
If Not Abstaining at Time of 
Interview, months at which 
relapse occurred after discharge 
21 0.93651 0.40548 1.46754 0.25000 0.03333 4.00000 1.166603 
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II. there was no association between educational grade and abstention 
III. there was an association between time of interview after discharge and abstention (z=-0.244, p=0.0145).   
a. Patients who abstained were interviewed early at a median of 2 months while those who 
relapsed were interviewed at a median of 5 months. 
IV. there was an association between length of substance use and abstention (z=-2.25, p=0.0243) 
a. Patients who abstained had used methamphetamine for shorter at 4.8 years while those who 
relapsed had used methamphetamine for longer at 7.5 years. 
DISCUSSION  
With a global illicit drug market in excess of U$320b coupled with a rising tide of methamphetamine abuse in 
South Africa and a lagging National Master Plan against illicit drug smuggling and abuse, effective rehabilitation 
programmes play an essential role in the fight against amphetamine abuse [11,49,50,51].  The successful 
implementation of South Africa's National Master Plan against illicit drugs has been hampered amongst other by 
frequent reports of police corruption and senior government officials being convicted of drug trafficking [49]. 
Maintaining rehabilitation programmes can be costly and it is therefore pertinent that the performance of these 
programmes be assessed regularly.  
This study has shown that the patients did not receive adequate aftercare after discharge from in-patient 
treatment. Final aftercare reporting was terminated too early i.e. at a mean of 3.8 months after discharge. This 
research therefore concludes that the performance of rehabilitation at De Novo treatment centre cannot be 
accurately assessed beyond 2 months for abstainers and 5 months for non-abstainers. International literature 
reviews recommend that assessments be done from 6 months onwards after discharge in order to get a more 
accurate assessment of the success of rehabilitation. This is so because the physiological effects of   
methamphetamine abuse persists for one to two years. Too early an assessment may give a false impression of 
the success of rehabilitation. The patients who self-reported abstention (73.6%) were assessed at a median time 
of 2 months. Thus, at a median of 2 months the De Novo treatment programme appeared to have performed well 
by having almost three quarters of its clients in abstention from methamphetamine use.  However, the longer it 
took to assess the patients after discharge the more likely they were found to have relapsed. This was shown 
when patients who were assessed later -at a median of 5 months after discharge -were found to have relapsed. 
Statistical analysis (ANOVA Mann Whitney U test) found this effect of “time of interview after discharge” unlikely 
to have occurred by chance. 
The mean age of amphetamine users of 24.6 as well as the male (69.2%) and female (30.8%) proportions is 
consistent with other studies done in South Africa [9].Co-using alcohol and prolonged use of methamphetamine 
had an effect on the outcome of rehabilitation. Avoidance of alcohol was found to be good for rehabilitation from 
methamphetamine abuse. Alcohol was found to be the only co-abused substance which - when not used together 
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with methamphetamine- was associated with a greater chance of abstaining. Co-abusing alcohol with 
amphetamines has been associated with increased risky sexual behavior and eventual development of psychiatric 
illness [52]. Using methamphetamine for a prolonged period i.e.  ≥ 7.5 years is associated with increased risk of 
relapse after discharge from rehabilitation. This group of patients might need special attention after discharge 
from in-patient treatment e.g.  regular and longer aftercare follow-up.   
There is an apparent contradiction when the outcome for the group who abstained is compared with the group 
who relapsed. Since the interviews were done early and most patients –who relapsed in the abstaining group- 
relapsed early, the relapsed group was expected to be larger. Instead the relapsed group was much smaller than 
the abstaining group. The explanation for this apparent contradiction lies in the relatively small number of cases 
(n=9) who initially relapsed and then later abstained. Also, the statistical analysis showed that the two groups 
(abstainers vs. those who relapsed) differed significantly i.e. it cannot be claimed with 100% certainty that all 
patients who relapsed would have ended up in the group of abstainers if they were interviewed earlier.     
The outcome of rehabilitation was not affected by patient age, gender, employment status, educational level, 
type of referral and co-using any other substances except alcohol. This finding was a surprise because it would be 
expected that being in employment gives patients stability and security and hence better motivation to abstain 
from amphetamine use. Level of education also did not affect treatment outcome. Similarly one would expect 
that a better education assists with greater insight, indirectly stability and security and hence better motivation to 
abstain from amphetamine use. Of note in this population is the generally poor level of education and high 
unemployment rate of all patients in the sample. Also a significant number of data about level of education was 
missing from folders. A potential confounding variable would have been patients referred by the criminal court. 
The patients referred by the criminal court had the same treatment outcome as voluntary patients. This 
corresponds with findings in other studies internationally [21]. Even if the patients referred by the criminal court 
had relapsed after discharge, there has been no clear evidence that these patients were routinely threatened 
with court action.   
The urine amphetamine test is the gold standard test to confirm abstinence. This test is not without limitations 
and not practical to use routinely during patient follow up. The next best test - and also much more practical to 
use -to confirm abstinence is the psychometric test. However, the test needs to be done with respect for certain 
internationally recommended standards. Even though there exists no agreement internationally as to which 
psychometric test is the most sensitive and specific  to use, at least the tests mentioned in this paper have been 
subjected to international study on numerous occasions [21,22,37,44,45]. The importance of having uniformity 
with psychometric tests must be emphasized because without uniformity it is difficult to compare rehabilitation 
outcomes nationally let alone internationally. De Novo has been using neither the amphetamine urine test nor 
one of the 6 psychometric tools mentioned above. The only instrument available was a standardised 
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questionnaire –which includes patient self- reporting of abstinence- used by counselors at De Novo during follow 
up visits after discharge from in-patient treatment.   
 
Doing a study at De Novo has proven to be a big challenge for the following two reasons: 
1) There is no international uniformity about the measuring tools to use to assess substance abuse [37,38]  
2) A section of the political system in South Africa i.e. The Promotion of Access to Information Act (PAIA) has 
made it virtually impossible to access patient folders at Rehabilitation centres like De Novo to conduct research 
[39]   
Given the health and socio-economic consequences of substance abuse coupled with the cost of maintaining 
rehabilitation programmes, the importance of dealing with this challenge in practice cannot be overstated.   
 
 
 
 
RECOMMENDATIONS 
1. Any national or regional plan aimed at dealing with the illegal distribution of illicit drugs must take 
cognizance of the current political and economic issues affecting the outcome of such plans. By this is 
meant that there are factors beyond the control of the Department of Social Development which may 
reduce the impact of its plans e.g. inadequate land and marine border control, different provincial 
political parties may implement the plan differently and national/provincial budget allocations may be 
inadequate for the successful implementation of plans. 
2. An adequate supply of aftercare workers must be made available. 
3.  International standards must be used as reference when drafting aftercare report templates e.g. ASI and 
CAUD. 
4. The Minister of Social Development must be informed of the continued need for resources for aftercare 
support. 
5. The minimum skills required by aftercare workers to do aftercare reporting and “care staff” must be 
clearly defined. 
6. Aftercare must be done for a minimum of 6 months after discharge. 
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7.  Aftercare report dates must by necessity be synchronized with institutional performance audits so that 
data collected from aftercare reports are useful for the auditing programme. Data is not useful when an 
aftercare report is done less than 6 months after discharge while the performance audits look at longer 
intervals of 6 and 12 months. 
8. Ways must be found to make aftercare a less laborious process, e.g. an electronic reporting template via 
cell phone and e-mail instead of faxing and physically transporting handwritten reports around. 
9.  Clients who co-abuse alcohol with amphetamine have a high risk of relapse. They must be given 
additional support over and above what is normally offered. 
10.  Cognitive behavior therapy and brief motivational interviewing – which is currently used by De Novo- 
have been the two most effective psychotherapeutic approaches internationally. These should not be 
abandoned  
11. A qualitative study is needed to assess reasons for the poor treatment outcome. 
 
STUDY LIMITATIONS 
1. All 91 cases had confirmed methamphetamine use documented in the folders. Reliability and validity of 
data was influenced by the fact that only partial copies of patient folders were made available. Hence 
information of some variables was not available or copied e.g. length of substance use prior to treatment 
and educational grade. No toxicology tests were performed in any of the cases. Only a psychometric 
instrument was used to assess the patients’ substance abuse. The aftercare questionnaire –psychometric 
instrument- does not have a reference or clear relation to any of the psychometric instruments used 
internationally e.g. ASI [43]. Validity of patient self–report was dependent on the interviewing skills of the 
aftercare reporters. 
2. Early cessation of aftercare reporting i.e. before 6 months after discharge set a limit on the amount of 
information available about treatment outcome. Treatment outcome beyond 6 months after discharge is 
not available 
3. Aftercare reports did not explicitly state the venue and whether patient privacy and confidentiality was 
guaranteed at interviews. The report needs to include information about the privacy and confidentially 
offered to the patient during the interview as well as the venue of the interview, etc.  Patients who are 
concerned about the privacy and confidentially of their information may not be willing to fully disclose 
their substance abuse to the interviewer 
4.  Some information was missing from folders e.g. educational qualifications and venue of the interview. 
This data could not be fully analysed. 
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CONCLUSION: 
Amphetamine abuse occur word wide. In South Africa, the Western Cape (1108%) and Eastern Cape (657%) has 
reported the highest increase in amphetamine use [8,9]. Amphetamine treatment outcome studies in South 
Africa and internationally are sparse. This study found that the provision of adequate rehabilitation from 
amphetamine abuse is a major challenge. Patients relapsed as early as two months after discharge from in-
patient treatment. The co-abuse of alcohol and amphetamine as well as prolonged use of amphetamine for ≥7.5 
years impacted negatively on the successful outcome of rehabilitation. This latter group of patients may require 
special attention during in-patient treatment and aftercare. The substance abuse programme at De Novo may 
benefit from the input of lessons learned from similar programmes elsewhere in South Africa and internationally. 
In particular, patients need to be followed up for at least 6 months after discharge from treatment. The median 
two month period of aftercare follow up of patients at De Novo was inadequate. 
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